-
1
-
-
33847155159
-
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
-
L.A. Mandell, R.G. Wunderink, A. Anzueto, and et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 suppl 2 2007 S27 S72
-
(2007)
Clin Infect Dis
, vol.44
, pp. S27-S72
-
-
Mandell, L.A.1
Wunderink, R.G.2
Anzueto, A.3
-
2
-
-
50649089808
-
The early bactericidal activity of anti-tuberculosis drugs: A literature review
-
P.R. Donald, and A.H. Diacon The early bactericidal activity of anti-tuberculosis drugs: a literature review Tuberculosis (Edinb) 88 suppl 1 2008 S75 S83
-
(2008)
Tuberculosis (Edinb)
, vol.88
, pp. S75-S83
-
-
Donald, P.R.1
Diacon, A.H.2
-
3
-
-
1442275724
-
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: A prospective, randomized study
-
M.W. Pletz, A. De Roux, A. Roth, K. Neumann, H. Mauch, and H. Lode Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study Antimicrob Agents Chemother 48 2004 780 782
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 780-782
-
-
Pletz, M.W.1
De Roux, A.2
Roth, A.3
Neumann, K.4
Mauch, H.5
Lode, H.6
-
4
-
-
33746599368
-
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis
-
W.J. Burman, S. Goldberg, J.L. Johnson, and et al. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis Am J Respir Crit Care Med 174 2006 331 338
-
(2006)
Am J Respir Crit Care Med
, vol.174
, pp. 331-338
-
-
Burman, W.J.1
Goldberg, S.2
Johnson, J.L.3
-
5
-
-
29444453676
-
Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis
-
S.H. Gillespie, R.D. Gosling, L. Uiso, N.E. Sam, E.G. Kanduma, and T.D. McHugh Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis J Antimicrob Chemother 56 2005 1169 1171
-
(2005)
J Antimicrob Chemother
, vol.56
, pp. 1169-1171
-
-
Gillespie, S.H.1
Gosling, R.D.2
Uiso, L.3
Sam, N.E.4
Kanduma, E.G.5
McHugh, T.D.6
-
6
-
-
0037871813
-
Treatment of tuberculosis: American Thoracic Society, CDC, and Infectious Diseases Society of America Centers for Disease Control and Prevention
-
Treatment of tuberculosis: American Thoracic Society, CDC, and Infectious Diseases Society of America Centers for Disease Control and Prevention MMWR Recomm Rep 52 RR11 2003 1 77
-
(2003)
MMWR Recomm Rep
, vol.52
, Issue.RR11
, pp. 1-77
-
-
-
7
-
-
0037097530
-
Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis
-
K.E. Dooley, J. Golub, F.S. Goes, W.G. Merz, and T.R. Sterling Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis Clin Infect Dis 34 2002 1607 1612
-
(2002)
Clin Infect Dis
, vol.34
, pp. 1607-1612
-
-
Dooley, K.E.1
Golub, J.2
Goes, F.S.3
Merz, W.G.4
Sterling, T.R.5
-
8
-
-
36549007398
-
Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease
-
P.D. Gaba, C. Haley, M.R. Griffin, and et al. Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease Arch Intern Med 167 2007 2317 2322
-
(2007)
Arch Intern Med
, vol.167
, pp. 2317-2322
-
-
Gaba, P.D.1
Haley, C.2
Griffin, M.R.3
-
9
-
-
65549120186
-
Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis
-
R. Long, H. Chong, V. Hoeppner, and et al. Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis Clin Infect Dis 48 2009 1354 1360
-
(2009)
Clin Infect Dis
, vol.48
, pp. 1354-1360
-
-
Long, R.1
Chong, H.2
Hoeppner, V.3
-
10
-
-
84865226888
-
Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death
-
Y.F. van der Heijden, F. Maruri, A. Blackman, and et al. Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death Int J Tuberc Lung Dis 16 2012 1162 1167
-
(2012)
Int J Tuberc Lung Dis
, vol.16
, pp. 1162-1167
-
-
Van Der Heijden, Y.F.1
Maruri, F.2
Blackman, A.3
-
11
-
-
85031884564
-
-
Available at: Accessed April 8, 2015
-
BC Centre for Disease Control British Columbia Tuberculosis Control 2005-2008 2008 Available at: http://www.bccdc.ca/NR/rdonlyres/4E5E68CC-12CD-42A5-88DC-7CE57E31FEAE/0/2005-2008MultiAnnualTBReport-LowResAmended-Nov10.pdf Accessed April 8, 2015
-
(2008)
British Columbia Tuberculosis Control 2005-2008
-
-
-
12
-
-
84878560475
-
-
WHO Geneva, Switzerland Available at: Accessed April 8, 2015
-
World Health Organization Global tuberculosis report 2013 2013 WHO Geneva, Switzerland 303 Available at: http://www.who.int/tb/publications/global-report/en/index.html Accessed April 8, 2015
-
(2013)
Global Tuberculosis Report 2013
, pp. 303
-
-
-
13
-
-
84960440049
-
-
Accessed April 8, 2015
-
Los Angeles County Tuberculosis Data. Available at: http://publichealth.lacounty.gov/tb/tbstats.htm. Accessed April 8, 2015.
-
Los Angeles County Tuberculosis Data
-
-
-
14
-
-
84960345504
-
-
Accessed April 8, 2015
-
New York City 2014 Tuberculosis Report. Available at: http://www.nyc.gov/html/doh/html/data/tb-reports.shtml. Accessed April 8, 2015.
-
New York City 2014 Tuberculosis Report
-
-
-
15
-
-
0029910831
-
How contagious is tuberculosis?
-
K.A. Sepkowitz How contagious is tuberculosis? Clin Infect Dis 23 1996 954 962
-
(1996)
Clin Infect Dis
, vol.23
, pp. 954-962
-
-
Sepkowitz, K.A.1
-
16
-
-
53349153767
-
Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands
-
A. Tostmann, S.V. Kik, N.A. Kalisvaart, and et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands Clin Infect Dis 47 2008 1135 1142
-
(2008)
Clin Infect Dis
, vol.47
, pp. 1135-1142
-
-
Tostmann, A.1
Kik, S.V.2
Kalisvaart, N.A.3
|